Logo image of MCN

XAI MADISON EQUITY PREMIUM I (MCN) Stock Price, Quote, News and Overview

NYSE:MCN - New York Stock Exchange, Inc. - US5574371002 - Currency: USD

6.25  +0.12 (+1.96%)

Fundamental Rating

3

Overall MCN gets a fundamental rating of 3 out of 10. We evaluated MCN against 0 industry peers in the Unkown industry. The financial health of MCN is average, but there are quite some concerns on its profitability. MCN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year MCN was profitable.
MCN had positive earnings in each of the past 5 years.
MCN had a negative operating cash flow in each of the past 5 years.
MCN Yearly Net Income VS EBIT VS OCF VS FCFMCN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

Industry RankSector Rank
ROA 9.8%
ROE 10.29%
ROIC 1.3%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MCN Yearly ROA, ROE, ROICMCN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10 15

1.3 Margins

In the last couple of years the Profit Margin of MCN has declined.
MCN's Operating Margin has improved in the last couple of years.
MCN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 60.5%
PM (TTM) 369.45%
GM 60.5%
OM growth 3Y71.47%
OM growth 5Y4.05%
PM growth 3Y-52.35%
PM growth 5Y-29.94%
GM growth 3Y71.26%
GM growth 5Y3.85%
MCN Yearly Profit, Operating, Gross MarginsMCN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K

More info and screens

4

2. Health

2.1 Basic Checks

There is no outstanding debt for MCN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MCN Yearly Shares OutstandingMCN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M
MCN Yearly Total Debt VS Total AssetsMCN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

2.2 Solvency

There is no outstanding debt for MCN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
MCN Yearly LT Debt VS Equity VS FCFMCN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
MCN Yearly Current Assets VS Current LiabilitesMCN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 128.00% over the past year.
The earnings per share for MCN have been decreasing by -26.43% on average. This is quite bad
MCN shows a strong growth in Revenue. In the last year, the Revenue has grown by 48.89%.
The Revenue has been growing slightly by 5.17% on average over the past years.
EPS 1Y (TTM)128%
EPS 3Y-38.6%
EPS 5Y-26.43%
EPS Q2Q%-67.66%
Revenue 1Y (TTM)48.89%
Revenue growth 3Y29.38%
Revenue growth 5Y5.17%
Sales Q2Q%44.25%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MCN Yearly Revenue VS EstimatesMCN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 8.56, which indicates a very decent valuation of MCN.
MCN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.15.
Industry RankSector Rank
PE 8.56
Fwd PE N/A
MCN Price Earnings VS Forward Price EarningsMCN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MCN Per share dataMCN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 11.75%, MCN is a good candidate for dividend investing.
MCN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.42.
Industry RankSector Rank
Dividend Yield 11.75%

5.2 History

MCN has paid a dividend for at least 10 years, which is a reliable track record.
MCN has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years14
MCN Yearly Dividends per shareMCN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

DPN/A
EPS Next 2YN/A
EPS Next 3YN/A
MCN Yearly Income VS Free CF VS DividendMCN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

More info and screens

XAI MADISON EQUITY PREMIUM I

NYSE:MCN (6/30/2025, 8:04:00 PM)

6.25

+0.12 (+1.96%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners15.78%
Inst Owner Change-2.62%
Ins Owners0.01%
Ins Owner Change0%
Market Cap132.00M
Analysts0
Price TargetN/A
Short Float %0.13%
Short Ratio0.3
Dividend
Industry RankSector Rank
Dividend Yield 11.75%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years14
Ex-Date06-16 2025-06-16 (0.06)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 8.56
Fwd PE N/A
P/S 31.89
P/FCF N/A
P/OCF N/A
P/B 0.89
P/tB 0.89
EV/EBITDA N/A
EPS(TTM)0.73
EY11.68%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.2
BVpS7.04
TBVpS7.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 9.8%
ROE 10.29%
ROCE 1.65%
ROIC 1.3%
ROICexc 1.3%
ROICexgc 1.3%
OM 60.5%
PM (TTM) 369.45%
GM 60.5%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y71.47%
OM growth 5Y4.05%
PM growth 3Y-52.35%
PM growth 5Y-29.94%
GM growth 3Y71.26%
GM growth 5Y3.85%
F-ScoreN/A
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)128%
EPS 3Y-38.6%
EPS 5Y-26.43%
EPS Q2Q%-67.66%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)48.89%
Revenue growth 3Y29.38%
Revenue growth 5Y5.17%
Sales Q2Q%44.25%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y115.88%
EBIT growth 3Y121.86%
EBIT growth 5Y9.43%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A